Drugs / Measles, Mumps and Rubella vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03148990 Comparator | Nov 2018 → Aug 2020 | measles, rubella | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps and Rubella vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03148990 ↗ |
| Known as | MMR | “Administration of the comparator vaccine (MMR).” NCT03148990 ↗ |
| Modality | Vaccine | “Administration of the comparator vaccine (MMR).” NCT03148990 ↗ |